Aside from their impact on membrane biophysics, our findings are particularly relevant for the development of allosteric activators of TMEM16A that may be beneficial for the treatment of obstructive airway diseases such as Cystic Fibrosis (Li et al., 2017; Mall and Galietta, 2015). Here, ANO1 is linked to cystic fibrosis.